Company: SHPH
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001641172-25-023263
Chunk: 2

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Item 3
Chunk 2
---

Not
Applicable.

ITEM
4. MINE SAFETY DISCLOSURES

Not
Applicable.

ITEM
5. OTHER INFORMATION

During
the quarter ended June 30, 2025, none of our directors or executive officers adopted or terminated any “Rule 10b5-1 trading arrangement”
or “non-Rule 10b5-1 trading arrangement” (as each item is defined Item 408(a) of Regulation S-K).

Item
6. Exhibits

The
following exhibits are filed or furnished with this report:

    Exhibit
    No.
     
    Description
    of Exhibit
  
    10.1
     
    Securities Purchase Agreement dated June 20, 2025 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on June 25, 2025)
  
    10.2
     
    Registration Rights Agreement dated June 20, 2025 (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed on June 25, 2025)
  
    10.3
     
    Form of Pre-Funded Warrant (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed on June 25, 2025)
  
    31.1
     
    Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
  
    31.2
     
    Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
  
    32.1
     
    Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
  
    32.2
     
    Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
  
    101.INS
     
    Inline
    XBRL Document Set for the financial statements and accompanying notes in Part I, Item 1, of this Quarterly Report on Form 10-Q.
  
    104
     
    Cover
    Page Interactive Data File